In 2006, a report in the New England Journal of Medicine alleged that Tequin had been found to put users at an elevated risk for dysglycemia, a blood sugar metabolism disorder that may manifest as either hyperglycemia (high blood sugar) or hypoglycemia (low blood sugar). Initially, Bristol-Myers Squibb notified health care providers that product warnings would be enhanced. However, the company subsequently opted to terminate the manufacture of Tequin. The product is now available only as treatment for eye conditions, in the form of an eye drop.
If you experienced side effects after being prescribed Tequin, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
Emotional distress is a real injury with serious consequences, and the law allows victims to seek compensation in many s... Read More
Landlords have a legal duty to keep rental homes safe and livable. When dangerous conditions go unaddressed, tenants may... Read More
Time is one of the most important factors in any legal dispute, yet it is also one of the most misunderstood. Every sta... Read More
How It Works